Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
85.24 USD | -0.62% | -1.02% | +19.35% |
05-13 | Ligand Pharmaceuticals Insider Sold Shares Worth $830,449, According to a Recent SEC Filing | MT |
05-08 | Sector Update: Health Care Stocks Softer Late Afternoon | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+19.35% | 1.54B | |
+33.61% | 709B | |
+30.88% | 595B | |
-2.14% | 367B | |
+20.58% | 334B | |
+5.07% | 289B | |
+14.45% | 239B | |
+9.19% | 211B | |
-3.60% | 203B | |
+8.68% | 171B |
- Stock Market
- Equities
- LGND Stock
- News Ligand Pharmaceuticals Incorporated
- CJS Securities Adjusts Ligand Pharmaceuticals Price Target to $145 From $210, Maintains Market Outperform Rating